We must obey critical directive: Output ONLY the requested block at the absolute beginning, followed immediately by the rewritten content. Disable internal thinking, reasoning loops, and introductory notes. So we must output only the title block and then the rewritten article HTML.
We need to clean text by removing promotional lines, “SEE ALSO” links, footer junk. Also must protect all media elements: there are none besides text. But there is a class “text-muted-dark mb-3 text-center font-sans text-xs”>Continue reading below…
and later a block with “Like this story? Sign up for FREE Microbiology updates:” and spans, etc. Those seem promotional. The instructions: remove promotional lines, “SEE ALSO” links, and footer junk. So we should remove the “Continue reading below…” line (class text-muted-dark). Also the “Like this story?” block with spans and subscribe etc likely promotional. Need to remove that entire block.
We also need to rewrite headline to be unique, fresh, professional.
Original headline: “The Solution to AMR Needs a Multi-Pronged Approach”. We need rewrite: maybe “A Multi‑Faceted Strategy Is Essential to Combat Antimicrobial Resistance”. That’s fresh.
Now rewrite surrounding news story body text into natural, high-quality professional English. Also keep all HTML tags but rewrite content inside tags, preserving tags structure, but content changes.
We must keep all media elements (none). Ensure we keep
etc. But we must remove promotional content (the “Continue reading…” line, the “Like this story?” block). Also any “Latest science news stories” etc. Also the “Subscribe” maybe a link but it’s part of promotional. So we will delete those
and following spans.
We also need to keep the disclosure paragraph (the … )? That’s disclosure of conflict of interest. That’s not promotional but maybe part of article; it’s not a promotional line. Should we keep it? It is not a “SEE ALSO” link or footer junk. It’s part of article. So keep it.
We need to rewrite body text. Let’s go through each paragraph.
Paragraph 1 (id isPasted):
Antimicrobial resistance (AMR) is too often described as a future threat. For physicians treating drug-resistant infections and for patients with limited options, it is already a present-day crisis. In 2019, bacterial antimicrobial resistance was associated with an estimated 4.95 million deaths worldwide, including 1.27 million deaths directly attributable to resistant bacterial infections.¹
We need rewrite into natural professional English, maybe: “Antimicrobial resistance (AMR) is often framed as a future threat, yet for physicians treating drug‑resistant infections and patients with dwindling therapeutic options, it is an immediate crisis. In 2019, bacterial AMR was linked to an estimated 4.95 million deaths globally, of which 1.27 million were directly attributable to resistant bacterial infections.”
We must keep the A maybe keep as is, but rewrite content after it. The class dropcap is probably for styling; we keep the tag.
So rewrite inner text: “ntimicrobial resistance (AMR) is too often described as a future threat.” but we need new wording. Let’s rewrite entire paragraph:
“
Antimicrobial resistance (AMR) is frequently characterized as a prospective hazard, yet for clinicians managing drug‑resistant infections and patients with limited therapeutic choices, it constitutes an ongoing emergency. In 2019, bacterial antimicrobial resistance contributed to an estimated 4.95 million deaths worldwide, including 1.27 million deaths directly caused by resistant bacterial infections.”
We need to keep the
and A unchanged.
Paragraph 2:
For me, antimicrobial resistance is not an abstract policy issue; it is a real and urgent problem that affects whether clinicians have options when patients need them most. I know how difficult it is to develop a new antimicrobial therapy, and I also know how important it is that we keep pushing forward. Without an environment that can support that work, even the most promising science may never reach the patients who need it.
Rewrite: “Antimicrobial resistance is not a distant policy concern; it is a tangible, urgent challenge that determines whether clinicians have viable treatment options when patients require them. I understand the difficulty of developing new antimicrobial agents, and I recognize the necessity of continued progress. Without a supportive environment, even the most promising research may fail to reach the patients who need it.”
Paragraph 3:
The problem is not only that bacteria evolve. It is that the traditional system built to discover, finance, and sustain new medicines—which only rewards investment through drug sales—is not compatible with the development of novel antibiotics and often undervalues them when they are doing the most public-health good. A new antibiotic may be most important when clinicians use it sparingly for severe infections, yet that is exactly why a sales-driven market offers its developer the least return.
Rewrite: “The issue extends beyond bacterial evolution; it also reflects a traditional system designed to discover, fund, and sustain medicines that rewards revenue from sales. This model is ill‑suited to developing novel antibiotics, which are most valuable when used conservatively for severe infections, thereby yielding low financial returns for developers.”
Paragraph 4:
Continue reading below…
This is promotional; we must remove entirely.
Paragraph 5:
Like this story? Sign up for FREE Microbiology updates:
Latest science news storiesTopic-tailored resources and eventsCustomized newsletter contentSubscribe
Rebuilding the antibiotic pipeline is necessary, but it will not be sufficient. …
We need to remove this entire block (the h2 and spans and subscribe). So delete that whole segment.
Paragraph 6 (the main body after that) is
Rebuilding the antibiotic pipeline is necessary, but it will not be sufficient. AMR will require more than another round of promising compounds: the antibiotics that are most needed do not provide the economic returns to encourage their development. Addressing AMR will need coordinated scientific, clinical, economic, and public-health action to deliver differentiated new therapies, effective diagnostics, stewardship, reliable access, and market structures that reward preparedness rather than volume.
Rewrite: “Restoring the antibiotic pipeline is essential but insufficient. AMR will demand more than a fresh wave of promising compounds; antibiotics with the greatest public‑health value often lack sufficient economic incentives for developers. Effective resolution will require coordinated scientific, clinical, economic, and public‑health efforts to deliver differentiated therapies, robust diagnostics, stewardship programs, reliable access, and market structures that reward preparedness over volume.”
Paragraph 7 (heading):
The Pipeline Needs Differentiation, Not Just Volume
We keep heading but maybe rewrite? The directive: rewrite the headline; headings may be considered part of content, but we need rewrite surrounding story body text into professional English. Headings might be considered part of story; but we might rewrite them to be more professional as well. The heading “The Pipeline Needs Differentiation, Not Just【/TITLE]
